Evidence map›Paper›PMID 40112208›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Imaging-Guided Microscale Photothermal Stereolithography Bioprinting.

Jingyu Sun, Tianqi Fang, Yuze Zhang, Jue Wang, Huan Han, Tsengming Chou, Junfeng Liang, Dilhan M Kalyon, Hongjun Wang, Shang Wang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Journal of biomedical optics · 2025
    Article
  2. Imaging-Guided Microscale Photothermal Stereolithography Bioprinting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jingyu SunDepartment of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Tianqi FangDepartment of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Yuze ZhangDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Jue WangDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Huan HanDepartment of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Tsengming ChouDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Junfeng LiangDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Dilhan M KalyonDepartment of Chemical Engineering and Materials Science, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Hongjun WangDepartment of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.
Shang WangDepartment of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ, 07030, USA.ORCID https://orcid.org/0000-0001-9447-719X

Funding

Multi-contrast dynamic optical imaging to advance live developmental biologyR35GM142953 · NIGMS · THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY · PI WANG, SHANG · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM142953NIH HHS R35GM142953Stevens Institute of Technology
6 · The paper itself

Abstract

Stereolithography bioprinting relies heavily on costly photoinitiators for polymerization, limiting its potential for further technical advancement to meet growing needs in tissue engineering and regenerative medicine. Thermal initiators, in contrast, are low cost, and rapid growth of the photothermal conversion field offers a wide range of materials and tools to convert light into heat. However, high-resolution photothermal stereolithography bioprinting remains unattainable due to the difficulty of confining heat in an aqueous environment. Here, this challenge has been fully addressed by establishing imaging-guided microscale photothermal stereolithography bioprinting (ImPSB). This technique is achieved through building a novel imaging-guided stereolithography system that provides depth-resolved visualization of the printing dynamics, creating a unique photothermal initiator in the second near-infrared window, and developing a new bioink by seeing and controlling the photothermal gelation process. ImPSB achieves a printing resolution of ≈47 µm and generates smooth lines of arbitrarily designed shapes with a cross-sectional diameter as small as ≈104 µm, representing an unprecedented scale from photothermal aqueous stereolithography. Its cellular biocompatibility in printing both bioscaffold and cell-laden hydrogel is demonstrated, and its feasibility of transdermal printing is also shown. This work sets a new path for high-resolution stereolithography bioprinting where the vast photothermal resources can be utilized.

Indexed as

BioprintingStereolithographyTissue EngineeringAnimalsHumansPrinting, Three-Dimensionalbioprintingimaging‐guided printingNIR‐II photothermal initiatoroptical coherence tomographystereolithography

Identifiers

PMID40112208
PMCPMC12079345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.